Eric Londin
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 17
- Cancer Genomics and Diagnostics 10
-
- RNA modifications and cancer 16
- RNA Research and Splicing 13
- CRISPR and Genetic Engineering 4
- RNA and protein synthesis mechanisms 4
- Co-authors
- Isidore RigoutsosPhillipe LoherAristeidis G. TelonisRogan MageePaolo FortinaJing YiJonathan R. BrodyKathleen Delgrosso
- Journals
- Cancer Research (8 papers)Scientific Reports (4 papers)Nucleic Acids Research (3 papers)BMC Genomics (3 papers)Clinical Chemistry (3 papers)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Eric Londin
61 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 1.3k
- Molecular Biology 2.1k
- Biological Psychiatry 45
- Oncology 340
- Genetics 286
Countries citing papers authored by Eric Londin
This map shows the geographic impact of Eric Londin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Londin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Londin more than expected).
Fields of papers citing papers by Eric Londin
This network shows the impact of papers produced by Eric Londin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Londin. The network helps show where Eric Londin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Londin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2021 | 26 | |
| 4 | 2019 | 72 | |
| 5 | 2019 | 63 | |
| 6 | 2018 | 41 | |
| 7 | 2018 | 28 | |
| 8 | 2018 | 39 | |
| 9 | 2018 | 19 | |
| 10 | 2017 | 84 | |
| 11 | 2017 | 41 | |
| 12 | 2017 | 64 | |
| 13 | 2017 | 147 | |
| 14 | 2017 | 161 | |
| 15 | 2016 | 18 | |
| 16 | 2015 | 1 | |
| 17 | 2014 | 83 | |
| 18 | 2013 | 11 | |
| 19 | 2011 | 36 | |
| 20 | 2004 | 52 |
About Eric Londin
Eric Londin is a scholar working on Cancer Research, Molecular Biology, Biological Psychiatry, Genetics and Ophthalmology, having authored 63 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (17 papers), RNA modifications and cancer (16 papers), RNA Research and Splicing (13 papers), Cancer Genomics and Diagnostics (10 papers), Genomics and Rare Diseases (5 papers), CRISPR and Genetic Engineering (4 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (2.1k citations), Biological Psychiatry (45 citations), Oncology (340 citations) and Genetics (286 citations). Eric Londin has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Isidore Rigoutsos, Phillipe Loher, Aristeidis G. Telonis, Rogan Magee, Paolo Fortina, Jing Yi, Jonathan R. Brody, Kathleen Delgrosso, Paul F. Bray and Adam Ertel. Their work appears in journals such as Cancer Research, Scientific Reports, Nucleic Acids Research, BMC Genomics and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.